PART 4: CLINICAL DOCUMENTS (EFFICACY DOCUMENTATION)

A : Table of Contents

A table of contents for the filed application should be provided.

B : Pre-Clinical Documentation
B1 : Pharmacology
B2 : Target Species Tolerance
B3 : Resistance
C: Clinical Documentation
C1: Summary of the Results and Critical Evaluation of Dose Determination and Dose Confirmation Studies and Clinical Trials
C2: Tabular Presentation of All Clinical Trials and Studies
C3: Individual Summary of the Most Important and Significant Studies
C4: Summary of Clinical Safety

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

 

 

Image   Image   Image   Image  

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Khamis 20 Jun 2024, 10:17:13.
© Copyright 2023 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Search

Menu Utama